Search results
AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But...
Benzinga via Yahoo Finance· 3 days agoEuropean pharma giant AstraZeneca Plc’s (NASDAQ:AZN) Covid vaccine, developed with the University of...
What's Driving AstraZeneca PLC's Surprising 14% Stock Rally?
Guru Focus· 7 days agoOver the past week, the company's stock price has climbed to $75.07, marking a significant gain of 10.16%. This upward trajectory is not limited to the short term; over the ...
AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
Investor's Business Daily· 7 days agoAstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after...
AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoAstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript April 25, 2024 AstraZeneca PLC misses...
AstraZeneca, Anglo American, Deutsche Bank: European Stocks in Focus
The Wall Street Journal· 7 days agoA slate of strong earnings and a potential megadeal helped drive the U.K.'s FTSE 100 index to...
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 7 days agoPreviously, a low single-digit percentage adverse impact was expected on core EPS. Our Take ...
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
Yahoo Finance via AOL· 7 days agoAstraZeneca's (AZN) stock is up following its latest earnings report Thursday after the company...
AstraZeneca PLC (LON:AZN) Beat Earnings, And Analysts Have Been Reviewing Their Forecasts
Simply Wall St. via Yahoo Finance· 5 days agoThere are some variant perceptions on AstraZeneca, with the most bullish analyst valuing it at...
AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance
Benzinga via Yahoo Finance· 7 days agoThursday, AstraZeneca Plc (NASDAQ:AZN) reported first-quarter sales of $12.68 billion, up 17% year...
Leerink Partnrs Equities Analysts Increase Earnings Estimates for AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 3 days agoAstraZeneca PLC (NASDAQ:AZN – Free Report) – Equities research analysts at Leerink Partnrs increased their FY2025 earnings estimates for AstraZeneca in ...